GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » EPS (Diluted)

Ananda Developments (AQSE:ANA) EPS (Diluted) : £-0.00 (TTM As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Developments EPS (Diluted)?

Ananda Developments's Earnings per Share (Diluted) for the six months ended in Jul. 2023 was £-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2023 was £-0.00.

Ananda Developments's EPS (Basic) for the six months ended in Jul. 2023 was £-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jul. 2023 was £-0.00.

Ananda Developments's EPS without NRI for the six months ended in Jul. 2023 was £-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jul. 2023 was £-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Ananda Developments EPS (Diluted) Historical Data

The historical data trend for Ananda Developments's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments EPS (Diluted) Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
EPS (Diluted)
- - - - -

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ananda Developments's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Developments's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ananda Developments's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Developments's PE Ratio distribution charts can be found below:

* The bar in red indicates where Ananda Developments's PE Ratio falls into.



Ananda Developments EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Ananda Developments's Diluted EPS for the fiscal year that ended in Jan. 2023 is calculated as

Diluted EPS (A: Jan. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.301-0)/850.991
=-0.00

Ananda Developments's Diluted EPS for the quarter that ended in Jul. 2023 is calculated as

Diluted EPS (Q: Jul. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.99-0)/2873.847
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Jul. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Developments  (AQSE:ANA) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Ananda Developments EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Ananda Developments's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Developments (AQSE:ANA) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments (AQSE:ANA) Headlines

No Headlines